Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

ANI Pharmaceuticals Inc

CUSIP: 00182C953 | 5 institutional holders

Quarters

Q3 2026 Q2 2026 Q3 2025 Q2 2025 Q1 2025

Compare Detailed Historical Funds Options Short Interest 13D/13G Peers Targeting Trading Summary Profile